Larson Financial Group’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Larson Financial Group's DFTX Position: Q3 2026 in Review
Larson Financial Group increased its Definium Therapeutics (DFTX) stake by 33% in Q3 2026, buying an estimated $7.42K and bringing the position to 717 shares worth $27.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1911.
Larson Financial Group first reported a position in DFTX in Q2 2021 and has held it in 10 quarters since. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Larson Financial Group held 717 shares of Definium Therapeutics worth $27.3K as of Q3 2026.
- Larson Financial Group bought 176 Definium Therapeutics shares in Q3 2026, an estimated $7.42K.
- Definium Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #1911 holding.
- Larson Financial Group first reported a position in Definium Therapeutics in Q2 2021 and has held it in 10 quarters since.
- 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.